Literature DB >> 31113740

Correlation between SOX2 and Survivin clinical features in patients with salivary adenoid cystic carcinoma.

Yejiao Luo1, Tong Liu1, Wei Fei2, Xiao-Guang Yue3.   

Abstract

OBJECTIVE: In this study, expression of cancer stem cells (CSCs)-related factor-Sex-determining region of Y chromosome-related high-mobility-group box 2 (SOX2) and anti-apoptotic specific factor- Survivin in salivary adenoid cystic carcinoma (SACC) was detected to provide important clues for effective SACC prevention and treatment by combining clinical pathological parameters analysis.
METHODS: Paraffin and fresh specimens were collected from SACC patients who underwent surgery at the Oral and Maxillofacial Surgery Department of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital. The experimental group was designed as SACC tissue, and the control group normal paracancerous normal gland tissue. (1) SOX2 and Survivin expression were detected using immunohistochemistry and analyzed by comnining clinical pathological parameter analysis. (2) mRNA and protein expression levels of SOX2 and Survivin were detected using RT-PCR, Western Blot.
RESULTS: 1. Immunohistochemistry: (1) SOX2 was mainly expressed on the nucleus. The SOX2 positive rate was 28.57% in clinical stage I-II, and 76.92% in stage III-IV. (2) Survivin was mainly expressed in the cytoplasm. The Survivin positive rate was 61.90% in clinical stage I-II, and 76.92% in stage III-IV. (3) There was a clear correlation between SOX2 and Survivin. 2. RT-PCR and Western Blot: The mRNA and protein expression levels of SOX2 and Survivin were significantly higher in the experimental group than in the control group (P < 0.01).
CONCLUSION: (1) The mRNA and protein expression level of SOX2 and Survivin was significantly higher in SACC tissues than in paracancerous normal salivary gland tissues, indicating that both of the two are tissue-specific and may become SACC oncogenes. (2) SOX2 and Survivin are significantly correlated in expression, which may coorinatively participate in SACC incidence and development.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer stem cells; SOX2; Salivary adenoid cystic carcinoma; Survivin

Mesh:

Substances:

Year:  2019        PMID: 31113740     DOI: 10.1016/j.jiph.2019.03.015

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  4 in total

1.  MicroRNA-140-5p inhibits salivary adenoid cystic carcinoma progression and metastasis via targeting survivin.

Authors:  Zhu Qiao; Yue Zou; Hu Zhao
Journal:  Cancer Cell Int       Date:  2019-11-16       Impact factor: 5.722

2.  Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression.

Authors:  Rina Di Bonaventura; Maurizio Martini; Tonia Cenci; Valerio Maria Caccavella; Valeria Barresi; Marco Gessi; Alessio Albanese; Liverana Lauretti; Roberto Pallini; Quintino Giorgio D'Alessandris; Alessandro Olivi
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

Review 3.  Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

Review 4.  Oral Cancer Stem Cells: Therapeutic Implications and Challenges.

Authors:  Linah A Shahoumi
Journal:  Front Oral Health       Date:  2021-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.